UGN-104

· UroGen Pharma Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for UGN-104, covering 2026-01-16 to 2026-01-16. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer [Phase 3]